Drug recall · January 8, 2025
phenylephrine in 0.9% Sodium Chloride Inj recall
Why: Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
phenylephrine in 0.9% Sodium Chloride Inj, 1mg per 10 mL (100 mcg/mL), Rx only, Hikma Injectables USA Inc., 36 Stults Road, Dayton, NJ 08810, NDC 63037-173-25
- Lots / codes
Lot number: 243120003D, Use by Date: 03/11/2025
- Company
- Hikma Injectables USA Inc, Dayton, NJ
- Distribution
- Nationwide in the USA
- Initiated
- December 19, 2024 · Voluntary: Firm initiated
- Classified
- January 2, 2025
- Reported
- January 8, 2025
- Ended
- November 12, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Phenylephrine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.